Wells Fargo’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,250
| Closed | -$995 | – | 7826 |
|
|
2023
Q1 | $995 | Sell |
2,250
-235
| -9% | -$92 | ﹤0.01% | 6381 |
|
|
2022
Q4 | $546 | Buy |
2,485
+1,046
| +73% | +$313 | ﹤0.01% | 6365 |
|
|
2022
Q3 | $0 | Sell |
1,439
-1
| -0.1% | -$1 | ﹤0.01% | 7961 |
|
|
2022
Q2 | $1K | Buy |
1,440
+16
| +1% | +$11 | ﹤0.01% | 6720 |
|
|
2022
Q1 | $1K | Buy |
1,424
+1
| +0.1% | +$1 | ﹤0.01% | 6956 |
|
|
2021
Q4 | $1K | Sell |
1,423
-15,992
| -92% | -$32.6K | ﹤0.01% | 7155 |
|
|
2021
Q3 | $43K | Buy |
17,415
+16,052
| +1,178% | +$44.5K | ﹤0.01% | 5688 |
|
|
2021
Q2 | $4K | Sell |
1,363
-10,468
| -88% | -$36.5K | ﹤0.01% | 6436 |
|
|
2021
Q1 | $41K | Sell |
11,831
-25,404
| -68% | -$141K | ﹤0.01% | 5912 |
|
|
2020
Q4 | $177K | Buy |
37,235
+4,362
| +13% | +$22.5K | ﹤0.01% | 5132 |
|
|
2020
Q3 | $159K | Sell |
32,873
-6,047
| -16% | -$28.6K | ﹤0.01% | 5081 |
|
|
2020
Q2 | $127K | Buy |
38,920
+7,320
| +23% | +$69.5K | ﹤0.01% | 5115 |
|
|
2020
Q1 | $162K | Sell |
31,600
-85,133
| -73% | -$344K | ﹤0.01% | 4811 |
|
|
2019
Q4 | $532K | Sell |
116,733
-209,372
| -64% | -$1.02M | ﹤0.01% | 4314 |
|
|
2019
Q3 | $2M | Sell |
326,105
-3,272
| -1% | -$19.5K | ﹤0.01% | 3330 |
|
|
2019
Q2 | $2.01M | Buy |
329,377
+19,152
| +6% | +$129K | ﹤0.01% | 3362 |
|
|
2019
Q1 | $1.72M | Buy |
310,225
+16,200
| +6% | +$105K | ﹤0.01% | 3483 |
|
|
2018
Q4 | $1.66M | Buy |
294,025
+149,475
| +103% | +$1.1M | ﹤0.01% | 3421 |
|
|
2018
Q3 | $1.52M | Buy |
144,550
+9,800
| +7% | +$105K | ﹤0.01% | 3640 |
|
|
2018
Q2 | $1.5M | Sell |
134,750
-6,000
| -4% | -$54K | ﹤0.01% | 3685 |
|
|
2018
Q1 | $1.13M | Buy |
140,750
+62,000
| +79% | +$495K | ﹤0.01% | 3825 |
|
|
2017
Q4 | $646K | Buy |
78,750
+2,500
| +3% | +$16.9K | ﹤0.01% | 4208 |
|
|
2017
Q3 | $473K | Buy |
76,250
+2,064
| +3% | +$12.7K | ﹤0.01% | 4371 |
|
|
2017
Q2 | $449K | Buy |
74,186
+26,436
| +55% | +$165K | ﹤0.01% | 4290 |
|
|
2017
Q1 | $253K | Buy |
47,750
+27,000
| +130% | +$157K | ﹤0.01% | 4676 |
|
|
2016
Q4 | $141K | Buy |
20,750
+19,500
| +1,560% | +$135K | ﹤0.01% | 4958 |
|
|
2016
Q3 | $9K | Hold |
1,250
| – | – | ﹤0.01% | 5798 |
|
|
2016
Q2 | $10K | Hold |
1,250
| – | – | ﹤0.01% | 5681 |
|
|
2016
Q1 | $7K | Hold |
1,250
| – | – | ﹤0.01% | 5817 |
|
|
2015
Q4 | $7K | Sell |
1,250
-110
| -8% | -$551 | ﹤0.01% | 5831 |
|
|
2015
Q3 | $5K | Buy |
1,360
+110
| +9% | +$498 | ﹤0.01% | 5877 |
|
|
2015
Q2 | $6K | Hold |
1,250
| – | – | ﹤0.01% | 5997 |
|
|
2015
Q1 | $5K | Hold |
1,250
| – | – | ﹤0.01% | 5852 |
|
|
2014
Q4 | $5K | Hold |
1,250
| – | – | ﹤0.01% | 5893 |
|
|
2014
Q3 | $5K | Hold |
1,250
| – | – | ﹤0.01% | 5846 |
|
|
2014
Q2 | $4K | Hold |
1,250
| – | – | ﹤0.01% | 5870 |
|
|
2014
Q1 | $4K | Hold |
1,250
| – | – | ﹤0.01% | 5612 |
|
|
2013
Q4 | $4K | Hold |
1,250
| – | – | ﹤0.01% | 5454 |
|
|
2013
Q3 | $5K | Hold |
1,250
| – | – | ﹤0.01% | 5313 |
|
|
2013
Q2 | $6K | Buy |
+1,250
| New | +$5.79K | ﹤0.01% | 5209 |
|
Other funds holding CEMI
Wells Fargo's CEMI Position: Q2 2023 in Review
Wells Fargo sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 2,250 shares — an estimated $995 sold.
Wells Fargo first reported a position in CEMI in Q2 2013 and held it in 40 quarters. The position peaked at $2.01M in Q2 2019. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.
- Wells Fargo reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 2,250 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $995.
- Wells Fargo first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 40 quarters.
- Wells Fargo's Chembio diagnostics, Inc. position peaked at $2.01M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.